Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 5000.00 | 1298.44 | 3283.00 | 5806.25 | 0.5654 | 0.5362 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 5000.00 | 1298.44 | 2805.00 | 5806.25 | 0.4831 | 0.4283 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 5000.00 | 1298.44 | 6043.00 | 5806.25 | 1.0408 | 1.0373 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 5000.00 | 1298.44 | 6091.00 | 5806.25 | 1.0490 | 1.0448 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 5000.00 | 1298.44 | 3109.00 | 5806.25 | 0.5355 | 0.4979 |
| SK-BR-3 | Nilotinib | 1 | uM | 5 | 5000.00 | 1298.44 | 5894.00 | 5806.25 | 1.0151 | 1.0139 |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5796.00 | 5806.25 | 0.9982 | 0.9984 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 5000.00 | 1298.44 | 5677.00 | 5806.25 | 0.9777 | 0.9793 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 5000.00 | 1298.44 | 6040.00 | 5806.25 | 1.0403 | 1.0369 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 5000.00 | 1298.44 | 5961.00 | 5806.25 | 1.0267 | 1.0245 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 5000.00 | 1298.44 | 2996.00 | 5806.25 | 0.5160 | 0.4725 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 5000.00 | 1298.44 | 3477.00 | 5806.25 | 0.5988 | 0.5775 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 5000.00 | 1298.44 | 5796.00 | 5806.25 | 0.9982 | 0.9984 |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 5000.00 | 1298.44 | 5349.00 | 5806.25 | 0.9213 | 0.9255 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 5 | 5000.00 | 1298.44 | 5545.00 | 5806.25 | 0.9550 | 0.9578 |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5842.00 | 5806.25 | 1.0062 | 1.0057 | |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5507.00 | 5806.25 | 0.9485 | 0.9516 | |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5761.00 | 5806.25 | 0.9922 | 0.9928 | |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5775.00 | 5806.25 | 0.9946 | 0.9950 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 5000.00 | 1298.44 | 5701.00 | 5806.25 | 0.9819 | 0.9831 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 5000.00 | 1298.44 | 5580.00 | 5806.25 | 0.9610 | 0.9636 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 5000.00 | 1298.44 | 5805.00 | 5806.25 | 0.9998 | 0.9998 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 5000.00 | 1298.44 | 5815.00 | 5806.25 | 1.0015 | 1.0014 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 5000.00 | 1298.44 | 5606.00 | 5806.25 | 0.9655 | 0.9678 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 5000.00 | 1298.44 | 5963.00 | 5806.25 | 1.0270 | 1.0248 |